Treatment of Progressive MS: Why, Who, When, How
Giancarlo Comi, MD
More Than “Women’s Issues": Women’s Reproductive and Gynaecological Health and Work
SPECIAL REPORT: Expert Opinion on New MS Drug Approval
Prof. Ralf Gold
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
The Diagnostic Challenges of Spinal Cord Lesions in MS
Jiwon Oh, MD, PhD, FRCPC
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Reducing the Burden of MS Treatment
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Multiple Sclerosis Physician Resources
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.
